United States SECURITIES AND EXCHANGE COMMISSION

                       Washington, DC  20549

                             FORM 10-QSB

(Mark One)
[X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 for the quarterly period ended  _July 30, 2005_ .

[ ] TRANSITION REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT for the transition period from ______________ to _____________.


Commission file number 0-1455



OPT-SCIENCES CORPORATION
(Exact name of small business issuer as specified in its charter)

NEW JERSEY
(State or other jurisdiction of incorporation or organization)

21-0681502
(IRS Employer Identification No.)


1912 Bannard Street, P.O. Box 221, Riverton, New Jersey  08077
(Address of principal executive offices)


856-829-2800
(Issuer's telephone number)


Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or
for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the
past 90 days.

YES [X]    NO [ ]

State the number of shares outstanding of each of the issuer's classes
of common equity, as of the latest practical date:

Class, Common Stock, par value of $.25 per share: 775,585 Shares
outstanding as of July 30, 2005

Transitional Small Business Format (Check one)  Yes [ ]   No [X]










INDEX                                                                     PAGE

PART I    Financial Information                                             3

Item 1.   Financial Statements                                              3

          Consolidated Balance Sheets - July 30, 2005(unaudited)
          and October 30, 2004                                              3

          Consolidated Statements of Income (unaudited) -
          thirteen and thirty-nine weeks ended July 30, 2005 and
          thirteen and thirty-nine weeks ended July 31, 2004                5

          Consolidated Statements of Cash Flows (unaudited)
          Thirty-nine weeks ended July 30, 2005 and Thirty-nine
          weeks ended July 31, 2004                                         6

          Notes to Consolidated Financial Statements                        7

Item 2.   Management's Discussion and Analysis or Plan of Operation         8

Item 3.   Controls and Procedures                                          12

PART II   Other Information                                                12

Item 1.   Legal Proceedings                                                12

Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds      12

Item 3.   Defaults Upon Senior Securities                                  12

Item 4.   Submission of Matters to a Vote of Security Holders              12

Item 5.   Other Information                                                12

Item 6.   Exhibits and Reports on Form 8-K                                 13

Signatures                                                                 13
















                   PART I    Financial Information

Item 1.    Financial Statements

                           Opt-Sciences Corporation
                           Consolidated Balance Sheets

ASSETS

                                     July 30, 2005          October 30, 2004
                                      (unaudited)
CURRENT ASSETS

Cash and cash equivalents           $ 5,020,390            $    4,770,451
Trade accounts receivable               632,608                   577,077
Inventories                             378,390                   444,726
Prepaid expenses                         36,365                    18,888
Loans and exchanges                       5,558                     5,615
Marketable securities                 1,316,593                 1,148,765

  Total current assets                7,389,904                 6,965,522


PROPERTY AND EQUIPMENT

Land                                    114,006                   114,006
Building and improvements               448,342                   448,342
Machinery and equipment               1,696,182                 1,692,263
Small tools                              53,580                    53,580
Furniture and fixtures                    8,624                     8,624
Office equipment                         57,481                    53,376
Automobiles                              85,605                    60,100

  Total property and
           equipment                  2,463,820                 2,430,291

  Less:  accumulated depreciation     1,572,998                 1,455,935

              Net property and
                 equipment              890,822                   974,356


OTHER ASSETS

Deposits                                  2,837                     2,837

Total assets                        $ 8,283,563            $    7,942,715








                                     -3-
LIABILITIES AND STOCKHOLDERS' EQUITY


                                      July 30, 2005          October 30, 2004
CURRENT LIABILITIES                     (unaudited)

Accounts payable - trade             $    54,931            $      108,563
Accrued income taxes                     198,573                    84,623
Deferred income taxes                     45,226                    43,620
Other current liabilities                131,071                   168,589

  Total current liabilities              429,801                   405,395


STOCKHOLDERS' EQUITY

    Common capital stock - par value
   $.025 per share - authorized
   and issued 1,000,000 shares           250,000                   250,000
    Additional paid in capital           272,695                   272,695
    Retained earnings                  7,538,719                 7,224,408
    Accumulated other comprehensive
         income:                         (20,434)                  (22,565)
    Less treasury stock at cost -
   224,415 shares and 224,415 shares    (187,218)                 (187,218)

   Total stockholders' equity          7,853,762                 7,537,320

            Total liabilities and
               stockholders' equity  $ 8,283,563            $    7,942,715


























                                     -4-
                         Opt-Sciences Corporation
                   Consolidated Statements of Income (unaudited)

                    Thirteen Weeks  Thirteen Weeks  Thirty-Nine   Thirty-Nine
                    Ended           Ended           Weeks Ended   Weeks Ended
                    July 30, 2005   July 31, 2004   July 30, 2005 July 31, 2004


Net Sales           $    799,788    1,033,428       $ 3,190,261   $ 2,859,647

Cost of Sales            586,321      792,105         2,221,283     2,428,026

Gross profit on sales    213,467      241,323           968,978       431,621


Operating Expenses

Sales & delivery          18,258        6,246            31,958        25,407
General and
   administrative        146,322      135,865           501,144       425,795

 Total operating
   expenses              164,580      142,111            533,102      451,202

 Operating income (loss)  48,887       99,212            435,876      (19,581)

Other Income              48,753       20,736            115,435       76,672


Income before taxes       97,640      119,948            551,311       57,091

Federal and State
  Income Taxes            42,000       14,300            237,000       14,300

 Net income               55,640      105,648            314,311       42,791

Retained Earnings -
  beginning of period  7,483,079    6,963,023          7,224,408    7,025,880

Retained Earnings -
  end of period     $  7,538,719 $  7,068,671        $ 7,538,719  $ 7,068,671


Earnings per Share of
  Common Stock      $       0.07 $       0.14        $      0.41  $      0.06

Average shares of stock
  outstanding             775585       775585             775585        775585








                                     -5-
                               Opt-Sciences Corporation
                          Statements of Cash Flows (unaudited)

                                             Thirty-Nine         Thirty-Nine
                                             Weeks Ended         Weeks Ended
                                             July 30, 2005       July 31, 2004

CASH FLOWS FROM OPERATING ACTIVITIES
Net income                                   $   314,311          $    42,791

Adjustments to reconcile net income to net
cash provided by operating activities:
Depreciation                                     117,063              118,622
(Gain) on sale of securities                     (15,878)             (11,346)

Decrease (increase) in:
Accounts receivable                              (55,531)              23,333
Inventories                                       66,336               46,670
Prepaid expenses                                 (17,477)               5,832
Prepaid income taxes                                  -0-              13,747
Loans and exchanges                                   57              (10,275)

(Decrease) increase in:
Accounts payable                                 (53,632)               5,716
Accrued income taxes                             113,950                  -0-
Other current liabilities                        (37,517)             (64,592)

Net cash provided (used) by
         operating activities                    431,682              170,498

CASH FLOWS FROM INVESTING ACTIVITIES
Additions to property and equipment              (33,529)             (24,366)
Purchases of securities                         (272,702)            (236,655)
Sales of securities                              124,488              234,796

Net cash (used) provided by
         investing activities                   (181,743)             (26,225)

Increase in cash                                 249,939              144,273

Cash and cash equivalents
at beginning of period                         4,770,451            4,227,416

Cash and cash equivalents
at end of period                            $  5,020,390         $  4,371,689

SUPPLEMENTAL DISCLOSURES:

Income taxes paid                           $    123,050           $       650







                                     -6-
Notes to Consolidated Financial Statements (Unaudited)

1.     Summary of Significant Accounting Policies

The accompanying consolidated financial statements include the accounts of Opt-
Sciences Corporation, Inc. and its wholly-owned subsidiary, O&S Research, Inc.
All significant intercompany accounts and transactions have been eliminated in
consolidation.

These consolidated financial statements have been prepared by the Company,
without audit, and reflect normal recurring adjustments which, in the opinion
of management, are necessary for a fair statement of the results of the third
quarter of the Company's fiscal year 2005.  These consolidated financial
statements do not include all disclosures associated with annual consolidated
financial statements and, accordingly, should be read in conjunction with
footnotes contained in the Company's consolidated financial statements for the
year ended October 30, 2004 together with the auditors' report filed under
cover of the Company's 2004 Annual Report on Form 10-KSB.

The preparation of these consolidated financial statements requires the Company
to make estimates and judgments that affect the reported amounts of assets,
liabilities, revenues and expenses. The Company bases its estimates on
historical experience and on various other assumptions that are believed to be
reasonable under the circumstances, the results of which form the basis for
making judgments about the carrying values of assets and liabilities that are
not readily apparent from other sources. Actual results may differ from these
estimates under different assumptions or conditions.

2.     Inventories

Inventories consisted of the following:

                                      July 30, 2005   October 30, 2004
                                       (Unaudited)

      Finished goods                    $ 74,164         $ 87,299
      Raw materials and supplies         116,923          137,211
      Work in progress                   187,303          220,216

            Total Inventory             $378,390         $444,726

End of quarter inventories are stated at the lower of cost (first-in, first-
out) or market and are based on estimates rather than a physical inventory. A
physical inventory is conducted at the end of the fiscal year. The Company
provides for estimated obsolescence on unmarketable inventory based upon
assumptions about future demand and market conditions. If actual demand and
market conditions are less favorable than those projected by management,
additional inventory write downs may be required. Inventory, once written down,
is not subsequently written back up, as these adjustments are considered
permanent adjustments to the carrying value of the inventory.  Historically,
the Company conducts a physical inventory annually in connection with its
certified financial statements and preparation of its Form 10KSB.  The
inventory appearing on unaudited quarterly financial statements and in Form
10QSB is based on estimates derived from the last physical inventory and
subsequent verifiable purchases of raw materials, sales of finished products,
and product orders in process of completion.
                                     -7-
3. Revenue Recognition

The Company recognizes revenue in accordance with U.S. GAAP and SEC Staff
Accounting Bulletin ("SAB") No. 104, Revenue Recognition. SAB No. 104 requires
that four basic criteria must be met before revenue can be recognized: (1)
persuasive evidence of an arrangement exists; (2) delivery has occurred or
services have been rendered; (3) the price to the buyer is fixed and
determinable; and (4) collectibility is reasonably assured. Determination of
criteria (3) and (4) are based on management's judgments regarding the fixed
nature of the price to the buyer charged for products delivered or services
rendered and collectibility of the sales price. The Company assesses credit
worthiness of customers based upon prior history with the customer and
assessment of financial condition. The Company's shipping terms are customarily
FOB shipping point.

4. Impairment of Long-Lived Assets and Long-Lived Assets to be Disposed of

In accordance with Statement of Financial Accounting Standards ("SFAS") No.
144, Accounting for the Impairment or Disposal of Long-Lived Assets, the
Company assesses impairment whenever events or changes in circumstances
indicate that the carrying amount of an asset may not be recoverable.
Recoverability of assets to be held and used is measured by a comparison of the
carrying amount of an asset to undiscounted future net cash flows expected to
be generated by the asset. Estimating the future cash flows expected to be
generated by the asset is dependent upon significant judgments made by
management. If such assets are considered to be impaired, the impairment to be
recognized is measured by the amount by which the carrying amount of the assets
exceeds the fair value of the assets.

5. Recently Issued Accounting Pronouncements

In November 2004, the FASB issued Statement of Financial Accounting Standards
No. 151, Inventory Costs, an amendment of ARB No. 43, which amends the guidance
in ARB No. 43, Chapter 4, "Inventory Pricing," to clarify the accounting for
abnormal amounts of idle facility expense, freight, handling costs, and wasted
material (spoilage). The provisions of this Statement are effective for
inventory costs incurred during fiscal years beginning after June 15, 2005. The
adoption of this statement is not expected to have a material impact on the
Company's consolidated financial statements.

Item 2. Management's Discussion and Analysis or Plan of Operation

Forward-Looking Statements

Information provided in this Quarterly Report on Form 10-QSB may contain
forward-looking statements within the meaning of Section 21E of Securities
Exchange Act of 1934 that are not historical facts and information. These
statements represent the Company's expectations or beliefs, such as statements
concerning future operating results, statements concerning industry
performance, the Company's operations, economic performance, financial
conditions, margins and growth in sales of the Company's products and capital
expenditures.  These forward looking statements include risks and
uncertainties, many of which are not within the Company's control, such as the
uncertainty of future demand for the Company's products; the uncertainty and
timing of the successful development of the Company's new products; the risks
associated with reliance on a few key customers; the Company's ability to
                                     -8-
attract and retain personnel with the necessary scientific and technical
skills; the timing and completion of significant orders; the timing and amount
of the Company's research and development expenditures; the timing and level of
market acceptance of customers' products for which the Company supplies
components; the level of market acceptance of competitors' products; the
ability of the Company to control costs associated with performance under fixed
price contracts; the performance and reliability of the Company's vendors;
potential product and contractual liability to its customers; and the continued
availability to the Company of essential supplies, materials and services.
Readers are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. The Company undertakes no
obligation to publicly release the result of any revision to these forward-
looking statements which may be made to reflect events or circumstances after
the date hereof or to reflect the occurrence of unanticipated events.

For this purpose, all statements contained in this Quarterly Report that are
not statements of historical fact may be deemed to be forward-looking
statements. These forward-looking statements are based on current expectations
and involve various risks and uncertainties that could cause actual results and
outcomes for future periods to differ materially from the forward-looking
statements or views expressed herein. The Company's financial performance and
the forward-looking statements contained herein are further qualified by other
risks including those set forth from time to time in the documents filed by the
Company with the Securities and Exchange Commission, including the Company's
most recent Form 10-KSB.

Business of the Company.

Overview.  Opt-Sciences Corporation, formed in 1956, conducts its business
through its wholly owned subsidiary, O & S Research, Inc. Both companies are
New Jersey corporations. As used in this Form 10-QSB, the term "Company" refers
to the combined operations of Opt-Sciences Corporation and O & S Research, Inc.
The principal business of the Company is to provide optical coatings, filters,
faceplates and lighting wedges which improve display readability for electronic
instruments used primarily in aircraft. This includes the application of
different types of anti-reflection coatings, transparent conductive coatings
and other optical coatings. The Company also provides full glass cutting,
grinding and painting operations which augment its optical coating
capabilities. Most of the Company's products are designed to enable pilots to
read aircraft instruments in direct sunlight or at night or in covert
situations using appropriate night vision filters. This business is a niche
business primarily dependent for its success on aircraft manufacturing and
retrofitting. It requires custom manufacturing of small lots of products to
satisfy component requirements for specific aircraft.

Critical Accounting Policies and Estimates

Management's discussion and analysis of financial condition and results of
operations are based upon the Company's consolidated financial statements,
which have been prepared in accordance with accounting principles generally
accepted in the United States of America ("U.S. GAAP"). The preparation of
these financial statements requires the Company to make estimates and judgments
that affect the reported amounts of assets, liabilities, revenues and expenses.
The Company bases its estimates on historical experience and on various other
assumptions that are believed to be reasonable under the circumstances, the
results of which form the basis for making judgments about the carrying values
                                     -9-
of assets and liabilities that are not readily apparent from other sources.
Actual results may differ from these estimates under different assumptions or
conditions.


Results of Operations

Sales of $799,788 for the third quarter of 2005 decreased 22.6% from 2004 third
quarter sales of $1,033,428, and decreased 37.8% from $1,287,058 in the second
quarter of fiscal 2005. Net income of $55,640 for the third quarter of 2005
compared to $105,648 for the third quarter of 2004. Cost of Sales for the third
quarter of 2005 was decreased approximately 26% from the same period in 2004.
In spite of the reduction in sales, the fact that the Company could profit at
all in the third quarter was attributed to aggressive cost cutting measures
such as working only four day work weeks and reducing engineering and maint-
enance expenses. These measures kept the gross profit margin for the first
three quarters at approximately 30%. If the Company hires additional technical
or administrative personnel, this margin may not be sustainable.  Operating
expenses of $164,580 for the third quarter of 2005 increased 15.8% over the
third quarter of fiscal 2004. This level of operating expenses is higher than
past years and is expected to increase in the future principally because of
additional expenses associated with Sarbanes-Oxley compliance. However, these
expenses have been slower to materialize than originally forecasted in fiscal
2004. The compliance date for section 404 of the Sarbanes-Oxley Act has been
postponed until 2007.

During the third quarter, the Company booked $757,000 in new orders, down
approximately $317,000 from the third quarter of 2004 and down approximately
$400,000 from the second quarter of 2005.  The backlog of orders stood at
$1,158,000 at the end of the third quarter. This is down approximately $39,000
from the end of the 2004 third quarter and down approximately $42,000 from the
end of the second quarter of 2005. The Company continues its efforts to reduce
its overdue orders which represent deferred shipments of approximately $50,000.

The higher than forecasted sales in the first two quarters were part of
unexpected customer requirements that were neither predicted nor forecasted for
last year. As a result of this large spike in demand, the Company's earnings
have increased significantly so far this year. The significant decline in third
quarter revenue and profitability was predicted in earlier quarters and
represents an order book adjustment. The large reduction in new orders booked
was primarily due to the large order increases from our main customers in the
first two quarters. Heading into the fourth quarter we project a rebound in
overall sales to approximately $1 million. We expect new orders booked to not
keep pace with sales resulting in an additional decline in the Company's order
backlog. As a result, based on current backlog of orders and available customer
order forecasts, we project sales for the first quarter of 2006 to be
approximately the same as the fourth quarter.




Financial Condition

The Company utilizes its working capital to finance current operations and
capital improvements. Cash and cash equivalents at the end of the third quarter
of 2005 increased $648,701 from the third quarter of 2004 and increased
                                     -10-
$249,939 from the second quarter of 2005. This increase from the same period
last year was largely due to revenues generated from sales and the sale of
securities. The Company maintains a strong liquidity in its current position in
order to improve its ability to deal with the risks and uncertainties
identified below.

Risks and Uncertainties

The future of our Company will depend, largely, on our ability to successfully
develop or acquire new products. There is no assurance, however, that we will
be successful in achieving market acceptance of the new products that we
develop or acquire. Failure to diversify our existing product offerings could
be harmful to our overall business, and could negatively affect results of
operations and financial condition.

The future market for the Company's aircraft instrument glass is shrinking due
to technological obsolescence and the use of larger displays in the cockpit and
the new display technologies.  Of the new display technologies, rear projection
displays cause the most concern to the Company because they do not use
components which the Company manufactures.  These display types are currently
used in many military aircraft applications and utilize a patented cover glass
that acts as a rear projection screen. The time frame for this technology
migrating to commercial/business avionic displays is currently unpredictable.
Larger primary instrument displays are eliminating the need for smaller,
specialized and otherwise redundant instruments. As unit volume for displays
declines, competition among vendors to maintain market share will become more
intense. We expect this competition will take the form of lower prices and
shorter delivery times. The opportunities to expand the existing product lines
are limited. New electro-mechanical displays which require glass wedges
manufactured by the Company are being purchased less frequently than LCD
displays which require a simpler, less expensive cover glass. The simpler
design will open the marketplace for prospective competitors who do not
otherwise have the ability to manufacture glass wedges.

We face increasing competition from established companies that have
significantly greater resources. Certain of our competitors enjoy substantial
competitive advantages, such as:

  - Greater corporate name recognition and larger marketing budgets and
    resources,
  - Established marketing relationships and access to larger customer bases,
    and
  - Substantially greater financial, technical and other resources.

   Section 404 of the Sarbanes-Oxley Act of 2002, requiring each company and its
public accounting firm to report on the effectiveness of the company's
internal controls over financial reporting, will first apply to the Company's
Annual Report on Form 10-KSB for the Fiscal Year 2007. The Company expects its
operating expenses will increase further as a result of the costs associated
with implementation of and maintaining compliance with Section 404 and
other provisions of the Sarbanes-Oxley Act.





                                     -11-
Item 3. Controls and Procedures

a.  Evaluation Of Disclosure Controls And Procedures.  Based on his evaluation
as of the end of the periods covered by this report, the Company's chief
executive officer and chief financial officer concluded that the Company's
disclosure controls and procedures referred to in paragraph 4(c) of his
Certification included as an exhibit to this report were effective.

b.  Changes In Internal Controls.  During the period covered by this report,
the Company has not made any change to its internal controls over financial
reporting as referred to in paragraph 4(d) of the Certification of the
Company's principal executive officer and principal financial officer included
as an exhibit to this report that has materially affected, or is reasonably
likely to materially affect the Company's internal control over financial
reporting.

PART II - Other Information

Item 1.  Legal Proceedings

         None.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

         None

Item 3.  Defaults upon Senior Securities

         Not applicable

Item 4.  Submission of Matters to a Vote of Security Holders

         None

Item 5.  Other Information

      Status of the Company's Reverse Stock Split.  On September 1, 2004 the
Board of Directors of the Company made a determination to amend the Articles of
Incorporation and implement a reverse stock split on the basis of 1:2,000
shares.  The purpose of this decision was to take the Company private and avoid
ongoing and increasing costs related to the public reporting status of the
Company and compliance with the Sarbanes-Oxley Act.  The principal stockholders
representing over 2/3 of the outstanding shares consented to such action.
Under New Jersey law, consent by 2/3 of the stockholders is sufficient without
the need of conducting a stockholders meeting.  On November 3, 2004, the
Company made preliminary filings of a Schedule 14C and a Schedule 13(e)3 with
the Securities and Exchange Commission.  The SEC responded to such filings on
December 3, 2004.  On January 20, 2005 the Company filed an amended Schedule
14C and an amended Schedule 13(e)3.  On February 9, 2005 the SEC provided the
Company a second letter of comments.  The Company continues to review the going
private action it has initiated.

From Management's perspective the Company revenues generated from the sale of
its products have become less predictable. The Company enjoyed unexpected
profitability for the first three quarters of this fiscal year. Our original
projections were based on maintaining existing staffing levels, lowered sales
                                     -12-
and significant expenses associated with the Sarbanes-Oxley Act("SOX")
compliance resulting in at best a breakeven year for fiscal 2005. However in
the latter part of fiscal 2004 the Company reduced engineering and maintenance
expenses by almost $250,000, increased sales modestly and deferred certain
costs for SOX compliance to 2007 due to a postponement by the SEC. These
changes have shown up as an increase in gross profit margin. Not all of these
cost savings are expected to be carried into 2006 as additional engineering
costs will be required for research and development.
The Company is continuing to review its plans for operational reorganization,
capital expenditure and product diversification.

Item 6.  Exhibits and Reports on Form 8-K

(a) Exhibits

    31.1 Certification of Chief Executive Officer and Chief Financial Officer
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
    32.1 Certification of Chief Executive Office and Chief Financial Officer
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

(b) Reports on Form 8-K:

    None

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the Registrant has duly caused this Report to be signed on its
behalf by the undersigned thereunder duly authorized.

                                                      OPT-SCIENCES CORORATION

                                                      By: /s/Anderson L. McCabe

                                                      ------------------------
                                                      Anderson L. McCabe
                                                      Chief Executive Officer
                                                      Dated: September 30, 2005
Exhibit 31.1

Certification of Chief Executive Officer and Chief Financial
Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
I, Anderson L. McCabe, as CEO and CFO of Opt-Sciences Corporation, certify
that:
1. I have reviewed this quarterly report of Opt-Sciences Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the small
business issuer as of, and for, the periods presented in this report;
4. I am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
                                     -13-
internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the small business issuer and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under my supervision, to ensure that
material information relating to the small business issuer, including its
consolidated subsidiaries, is made known to me by others within those entities,
particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such
internal control over financial reporting to be designed under my supervision,
to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the small business issuer's disclosure
controls and procedures and presented in this
report my conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period
covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the small business issuer's internal
control over financial reporting that
occurred during the small business issuer's most recent fiscal quarter that has
materially affected, or is reasonably likely to materially affect, the small
business issuer's internal control over financial reporting; and
5. I have disclosed, based on my most recent evaluation of internal control
over financial reporting, to the small business issuer's auditors and the audit
committee of the small business issuer's board of directors (or persons
performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial
reporting which are reasonably likely to adversely affect the small business
issuer's ability to record, process, summarize
and report financial information; and
(b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the
small business issuer's internal control over financial reporting.

                                       /s/Anderson L. McCabe

                                       ---------------------
                                       Name: Anderson L. McCabe
                                       Title: Chief Executive Officer/
                                              Chief Financial Officer
                                       Dated: September 30, 2005

Exhibit 32.1

Certification of Chief Executive Officer and Chief Financial
Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

I, Anderson L. McCabe as CEO and CFO of Opt-Sciences Corporation (the
"Company"), certify to my knowledge, pursuant to section 906 of the Sabanes-
Oxley Act of 2002,18 U.S.C. Section 1350, that:(1)the Quarterly Report on Form
10-QSB of the Company for the quarterly period ended July 30, 2005 (the
"Report") fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and (2)the
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
                                     -14-
                                       /s/Anderson L. McCabe

                                       ---------------------
                                       Name: Anderson L. McCabe
                                       Title: Chief Executive Officer/
                                              Chief Financial Officer
                                       Dated: September 30, 2005